[HTML][HTML] Dopamine D3 receptor: A neglected participant in Parkinson Disease pathogenesis and treatment?

P Yang, JS Perlmutter, TLS Benzinger, JC Morris… - Ageing research …, 2020 - Elsevier
Parkinson disease (PD) is a neurodegenerative disorder characterized by motor and non-
motor symptoms which relentlessly and progressively lead to substantial disability and …

Dopamine D2-like receptors on conditioned and unconditioned fear: A systematic review of rodent pharmacological studies

C de Oliveira Alves, I Waku, JN Chiossi… - Progress in Neuro …, 2024 - Elsevier
Growing evidence supports dopamine's role in aversive states, yet systematic reviews
focusing on dopamine receptors in defensive behaviors are lacking. This study presents a …

Chronic D2/3 agonist ropinirole treatment increases preference for uncertainty in rats regardless of baseline choice patterns

M Tremblay, MM Silveira, S Kaur… - European Journal of …, 2017 - Wiley Online Library
D2/3 receptor agonists are effective treatments for Parkinson's disease (PD), but can
precipitate impulse control disorders (ICD s) including gambling disorder (GD). The …

Striatopallidal neurons control avoidance behavior in exploratory tasks

KH LeBlanc, TD London, I Szczot, ME Bocarsly… - Molecular …, 2020 - nature.com
The dorsal striatum has been linked to decision-making under conflict, but the mechanism
by which striatal neurons contribute to approach-avoidance conflicts remains unclear. We …

A selective D2 dopamine receptor agonist alleviates depression through up-regulation of tyrosine hydroxylase and increased neurogenesis in hippocampus of the …

M Fatima, MH Ahmad, S Srivastav, MA Rizvi… - Neurochemistry …, 2020 - Elsevier
Prenatal stress (PNS) has its negative impact on both the infant hippocampal neurogenesis
and pregnancy outcomes in the neonates that serves as a risk factor for postnatal …

Serotonergic Neurotransmission System Modulator, Vortioxetine, and Dopaminergic D2/D3 Receptor Agonist, Ropinirole, Attenuate Fibromyalgia-Like Symptoms in …

K Sałat, A Furgała-Wojas - Molecules, 2021 - mdpi.com
Fibromyalgia is a disease characterized by lowered pain threshold, mood disorders, and
decreased muscular strength. It results from a complex dysfunction of the nervous system …

Behavioral, cellular and molecular responses to cold and mechanical stimuli in rats with bilateral dopamine depletion in the mesencephalic dopaminergic neurons

M Elshennawy, O Ouachikh, Y Aissouni, S Youssef… - Neuroscience, 2021 - Elsevier
Pain is the major non-motor symptom in Parkinson's disease (PD). Preclinical studies have
mostly investigated mechanical pain by considering the decrease in a nociceptive threshold …

DRD3 Predicts Cognitive Impairment and Anxiety in Parkinson's Disease: Susceptibility and Protective Effects

A Gonçalves, A Mendes, J Damásio… - Journal of …, 2024 - content.iospress.com
Background: A possible genetic contribution of dopamine D3 receptor (DRD3) to cognitive
impairment in Parkinson's disease (PD) has yet to be investigated. Objective: To explore the …

'Dopamine agonist Phobia'in Parkinson's disease: when does it matter? Implications for non-motor symptoms and personalized medicine

S Rota, I Boura, L Batzu, N Titova… - Expert Review of …, 2020 - Taylor & Francis
Introduction Dopamine agonists have been widely used to treat patients with Parkinson's
disease, but concerns related to their well-known side effects might prevent their use even …

Partial ablation of postsynaptic dopamine D2 receptors in the central nucleus of the amygdala increases risk avoidance in exploratory tasks

E Casey, ME Avale, A Kravitz, M Rubinstein - Eneuro, 2022 - eneuro.org
The central nucleus of the amygdala (CeA) is involved in the expression of fear and has
been implicated in several anxiety disorders. This structure is densely innervated by DAergic …